This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Burkina Faso

  1. Mosquito nets treated with new ingredients show greater reductions in malaria than standard insecticide-treated nets.
    Published: December 2021
    Type: Article
  2. The New Nets Project was established with the goal of making the latest resistance breaking net technology more widely available to malaria programs throughout Africa. As well as managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, the New Nets Project partners oversee randomized control trials and pilots. The evidence gathered from these will be used to ascertain the impact and cost-effectiveness of the nets and support an appropriate policy recommendation from the World Health Organization (WHO). The New Nets Project is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and USAID. The project is led by IVCC. This report shares interim findings from the five observational studies led by PATH.
    Published: December 2021
    Type: Resource Page
  3. PATH and partners are helping countries make better investments in digital health by learning from those leading the way.
    Published: November 2021
    Type: Article
  4. In West Africa and around the world, scaling up access to oxygen is one of the most effective, and critical, actions that decision-makers can take to improve health outcomes, particularly for vulnerable populations such as newborns, children, and pregnant women. The COVID-19 pandemic has further emphasized the vital role of respiratory care for patients struggling to breathe. Respiratory care requires investment in strengthening health care delivery systems, including supply management and provider training.This brief summarizes Senegal’s and Burkina Faso’s efforts toward establishing a comprehensive and sustainable oxygen system to address respiratory care needs beyond COVID-19, and demonstrates the type of support PATH can provide in this process.
    Published: October 2021
    Type: Resource Page
  5. A great deal of knowledge already exists in the global health community regarding maternal, neonatal, and child health (MNCH) medical devices and the challenges/barriers they face. But this knowledge is currently scattered across a variety of donor, partner, country, and academic sources, and as a result, is not easily accessible to the broader community. As such, PATH—under the Market Dynamics for MNCH Medical Devices project (MD4MD)—conducted a rapid desk research exercise focused on compiling information that was either publicly available or easily accessible, including: published literature, multilateral organization resources (such as policy briefs, technical reports, and guidelines); implementing partner projects (such as assessments, landscapes, and technical reports); donor investment documents; and expert interviews with relevant project leads and medical device experts.This evidence review focuses on eight specific devices: (1) manual blood pressure cuff (sphygmomanometer); (2) electric bCPAP device; (3) neonatal resuscitation device; (4) x-ray radiography machine; (5) point-of-care hemoglobin meter; (6) infusion device; (7) ultrasound (app-based “pocket” devices); and (8) ultrasound (traditional portable devices).The goal of these documents is to (1) summarize for policymakers and health system leaders the most important barriers that MNCH devices face, and (2) highlight potential interventions and key knowledge gaps to prioritize with future investments.
    Published: July 2021
    Type: Resource Page
  6. Medical devices play an essential role in the prevention, diagnosis, and treatment of maternal, neonatal, and child health (MNCH) in low- and middle-income countries. However, medical devices have unique characteristics that make them difficult to manage effectively, particularly in low-resource settings.As countries experience rising life expectancy and a shift toward noncommunicable disease burden, demand is growing rapidly for device-intensive services like life support and chronic disease management. There is also an expectation that this growing need will be met with domestic rather than donor resources as countries move up in income status. Strengthening access to medical devices is therefore a critical area for health system investment.This fact sheet offers an overview of the Market Dynamics for MNCH Medical Devices project (MD4MD), which aims to diagnose key barriers that impede access to MNCH medical devices in low- and middle-income countries and prioritize potential solutions to address these barriers.
    Published: March 2021
    Type: Resource Page
  7. During the COVID-19 pandemic, governments around the world have rapidly introduced policies to mitigate service disruptions to RMNCAH,N care using innovative adaptations such as telehealth or task shifting. As part of our ongoing COVID-19 Essential Health Services Policy Tracker project supported by the Bill & Melinda Gates Foundation, PATH developed a set of briefs that explore in detail the service delivery adaptations outlined in pandemic-era government policies in five countries (Burkina Faso, Ethiopia, India, Nigeria, and Pakistan) to equip country leaders, donors, and advocates with tactics for maintaining essential health services through the pandemic and beyond.(French translation available for brief on Burkina Faso)
    Published: February 2021
    Type: Resource Page
  8. The New Nets Project, a partnership funded by Unitaid and the Global Fund and led by IVCC, aims to accelerate the scale-up of next-generation, dual-active ingredient ITNs and to provide National Malaria Control Programs, donors, and implementers with clear evidence of their impact on malaria burden.
    Published: September 2020
    Type: Resource Page
  9. This brief summarizes the experience and capabilities of the PATH HPV Vaccine Team. For decades, PATH has been at the forefront of evidence-based strategies from HPV vaccine research and delivery to cervical cancer screening and treatment to ensure we best meet the needs and realities of these countries for the greatest health impact.
    Published: June 2020
    Type: Resource Page
  10. This brief summarizes the experience and capabilities of the PATH Cervical Cancer Team. For decades, PATH has been at the forefront of evidence-based strategies from HPV vaccine research and delivery to cervical cancer screening and treatment to ensure we best meet the needs and realities of these countries for the greatest health impact.
    Published: June 2020
    Type: Resource Page
Load more